| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.03▼ | 2.05▼ | 2.06▼ | 2.10▼ | 2.12▼ |
| MA10 | 2.03▼ | 2.06▼ | 2.09▼ | 2.11▼ | 2.56▼ |
| MA20 | 2.04▼ | 2.09▼ | 2.11▼ | 2.17▼ | 2.84▼ |
| MA50 | 2.06▼ | 2.10▼ | 2.11▼ | 2.67▼ | 2.39▼ |
| MA100 | 2.09▼ | 2.11▼ | 2.10▼ | 2.89▼ | 10.54▼ |
| MA200 | 2.10▼ | 2.12▼ | 2.52▼ | 2.42▼ | 18.26▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.007▼ | -0.012▼ | 0.027▲ | -0.060▼ |
| RSI | 30.070▼ | 29.227▼ | 32.811▼ | 36.604▼ | 38.477▼ |
| STOCH | 16.667▼ | 2.473▼ | 6.656▼ | 37.939 | 7.405▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -75.000 | -97.351▼ |
| CCI | -106.161▼ | -179.925▼ | -153.922▼ | -45.823 | -105.958▼ |
|
Monday, January 19, 2026 07:19 AM
As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints The paper provides a detailed analysis of the RETHINK-ALZ and REFOCUS-ALZ ...
|
|
Monday, December 22, 2025 04:00 PM
AUSTIN, Texas, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for ...
|
|
Wednesday, November 12, 2025 12:38 PM
The MarketWatch News Department was not involved in the creation of this content. -- Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 2.13 | 2.16 | 2.02 | 2.04 | 1,167,621 |
| 15/01/26 | 2.13 | 2.16 | 2.105 | 2.13 | 298,813 |
| 14/01/26 | 2.08 | 2.19 | 2.07 | 2.15 | 753,900 |
| 13/01/26 | 2.13 | 2.1468 | 2.03 | 2.05 | 773,356 |
| 12/01/26 | 2.10 | 2.13 | 2.03 | 2.12 | 692,000 |
| 09/01/26 | 2.14 | 2.21 | 2.10 | 2.10 | 552,600 |
| 08/01/26 | 2.16 | 2.19 | 2.12 | 2.14 | 594,600 |
| 07/01/26 | 2.14 | 2.28 | 2.13 | 2.18 | 1,091,500 |
| 06/01/26 | 2.10 | 2.15 | 2.07 | 2.12 | 553,300 |
| 05/01/26 | 2.12 | 2.16 | 2.06 | 2.10 | 819,400 |
|
|
||||
|
|
||||
|
|